Evidence map›Paper›PMID 34898476›Full record

ArticleAging2021

Late-life fasting imparts resiliency and protein persulfidation.

Jie Yang, Betemariam Sharew, Christopher Hine

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jie YangDepartment of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA.
Betemariam SharewDepartment of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA.
Christopher HineDepartment of Cardiovascular and Metabolic Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA.

Funding

Iron Catalyzed H2S and its Prevalence in Hemolytic and Iron Overload DisordersR01HL148352 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI HINE, CHRISTOPHER MICHAEL · 2019 to 2021
$964k
Requirement of hydrogen sulfide for the benefits of dietary sulfur amino acid restrictionR00AG050777 · NIA · CLEVELAND CLINIC LERNER COM-CWRU · PI HINE, CHRISTOPHER MICHAEL · 2017 to 2019
$747k
Requirement of hydrogen sulfide for the benefits of dietary sulfur amino acid restrictionK99AG050777 · NIA · HARVARD SCHOOL OF PUBLIC HEALTH · PI HINE, CHRISTOPHER MICHAEL · 2015 to 2016
$257k
NHLBI NIH HHS R01 HL148352NIA NIH HHS K99 AG050777NIA NIH HHS R00 AG050777
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Protein Processing, Post-TranslationalAgingAnimalsCysteineFastingHumansSulfhydryl CompoundsCysteineSulfhydryl Compoundscystathionine γ-lyase (CGL)Every-other-Day (EOD) fastinghydrogen sulfide (HS) 2persulfidation

Identifiers

PMID34898476
PMCPMC8714142

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.